GDTC
Price
$0.83
Change
-$0.02 (-2.35%)
Updated
Feb 4, 01:48 PM (EDT)
Capitalization
9.97M
89 days until earnings call
Intraday BUY SELL Signals
JSPR
Price
$1.33
Change
-$0.10 (-6.94%)
Updated
Feb 4, 02:55 PM (EDT)
Capitalization
40.3M
Intraday BUY SELL Signals
Interact to see
Advertisement

GDTC vs JSPR

Header iconGDTC vs JSPR Comparison
Open Charts GDTC vs JSPRBanner chart's image
CytoMed Therapeutics
Price$0.83
Change-$0.02 (-2.35%)
Volume$200
Capitalization9.97M
Jasper Therapeutics
Price$1.33
Change-$0.10 (-6.94%)
Volume$14.89K
Capitalization40.3M
GDTC vs JSPR Comparison Chart in %
GDTC
Daily Signal:
Gain/Loss:
JSPR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GDTC vs. JSPR commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Hold and JSPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (GDTC: $0.85 vs. JSPR: $1.44)
Brand notoriety: GDTC and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 11% vs. JSPR: 12%
Market capitalization -- GDTC: $9.97M vs. JSPR: $40.3M
GDTC [@Biotechnology] is valued at $9.97M. JSPR’s [@Biotechnology] market capitalization is $40.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 1 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • GDTC’s FA Score: 1 green, 4 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 5 TA indicator(s) are bullish while JSPR’s TA Score has 3 bullish TA indicator(s).

  • GDTC’s TA Score: 5 bullish, 2 bearish.
  • JSPR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, GDTC is a better buy in the short-term than JSPR.

Price Growth

GDTC (@Biotechnology) experienced а +1.71% price change this week, while JSPR (@Biotechnology) price change was -12.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

GDTC is expected to report earnings on May 04, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($40.3M) has a higher market cap than GDTC($9.97M). JSPR YTD gains are higher at: -21.311 vs. GDTC (-36.330).
GDTCJSPRGDTC / JSPR
Capitalization9.97M40.3M25%
EBITDAN/A-92.32M-
Gain YTD-36.330-21.311170%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A50.9M-
Total DebtN/A1.7M-
FUNDAMENTALS RATINGS
JSPR: Fundamental Ratings
JSPR
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GDTCJSPR
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 15 days ago
87%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GDTC
Daily Signal:
Gain/Loss:
JSPR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LBRDA49.40-0.23
-0.46%
Liberty Broadband Corp
SDST3.94-0.13
-3.19%
Stardust Power Inc.
AVGO320.33-10.78
-3.26%
Broadcom Inc.
AGL0.76-0.06
-7.78%
agilon health
JJSF80.50-14.70
-15.44%
J & J Snack Foods Corp

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-1.16%
CYCN - GDTC
35%
Loosely correlated
-10.14%
CVKD - GDTC
29%
Poorly correlated
-7.04%
QSI - GDTC
28%
Poorly correlated
-0.91%
ADIL - GDTC
27%
Poorly correlated
-1.58%
JSPR - GDTC
27%
Poorly correlated
-2.04%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-2.04%
AUPH - JSPR
44%
Loosely correlated
-0.07%
APGE - JSPR
43%
Loosely correlated
+4.97%
ETHZ - JSPR
38%
Loosely correlated
-1.30%
XNCR - JSPR
37%
Loosely correlated
-0.99%
VYGR - JSPR
36%
Loosely correlated
-2.25%
More